Oligonucleotide synthesis companies play a crucial role in the field of molecular biology and biotechnology by providing custom oligonucleotides—short sequences of nucleotides typically used in various applications, including DNA and RNA research. These companies offer services that cater to the diverse needs of researchers, diagnostic labs, pharmaceutical companies, and other entities involved in life sciences.
Sep 2023: The previously announced merger between the musculoskeletal solutions business Globus Medical and the spine technology company NuVasive has been completed. Globus Medical and Nuvasive reached an agreement in February of this year to purchase Nuvasive in an all-stock deal estimated to be worth $3.1 billion. The combined business will significantly influence the continuum of care by providing surgeons and patients with a wide range of musculoskeletal procedural treatments and technologies. Additionally, it will enhance operational capability, surgeon training, and product development. The combination is also anticipated to offer a stronger chance for more revenue and a solid financial base to create value. The extension of Globus Medical's board of directors from eight to eleven members has been approved following the terms specified in the merger agreement with NuVasive. Globus Medical and NuVasive have merged, combining their significant spine and orthopedic portfolios, global footprint, and commercial reach.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)